|
Real-time Estimate
Tradegate
03:46:48 21/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 0.7700 EUR | +3.36% |
|
+0.40% | +428.17% |
| 17/08 | Valerio Therapeutics Nears Final Deal for Etherna Immunotherapies Purchase | MT |
| 16/07 | Valerio Therapeutics, Abivax Enter R&D Collaboration for Inflammatory Disease Therapies | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,141B | |||||
| 659B | - | - | - | ||
| 470B | |||||
| 366B | |||||
| 302B |
Select your edition
All financial news and data tailored to specific country editions
